Acute autoimmune hemolytic anemia with transient aplastic crisis likely triggered by Parvovirus B19 infection in an adolescent: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260738Keywords:
Autoimmune hemolytic anemia, Parvovirus B19, Aplastic crisis, Pediatric hemolysisAbstract
Autoimmune hemolytic anemia (AIHA) is an uncommon but potentially life-threatening disorder characterized by immune-mediated destruction of red blood cells. Parvovirus B19 infection is a well-recognized cause of transient aplastic crisis due to suppression of erythroid precursors, and the simultaneous occurrence of immune hemolysis with marrow suppression presents a diagnostic challenge. We report the case of a 13-year-old boy who presented with fever, jaundice, and dark-colored urine. Laboratory evaluation revealed severe anemia (hemoglobin 5.5 g/dl), indirect hyperbilirubinemia, and a positive direct antiglobulin test confirming AIHA. Notably, the reticulocyte count was inappropriately low for the degree of hemolysis, suggesting transient marrow suppression. Extensive autoimmune and infectious investigations were largely negative except for equivocal parvovirus B19 IgM serology. The patient showed significant clinical and hematological improvement following packed red blood cell transfusion and corticosteroid therapy. This case highlights the importance of considering Parvovirus B19 infection in AIHA patients presenting with reticulocytopenia, as early recognition and appropriate supportive management are essential to prevent serious complications.
Metrics
References
Ghimire A, Platnich JM, Chauhan U. Warm autoimmune hemolytic anemia and pure red cell aplasia during a severe COVID-19 B.1.1.7 infection. Infect Dis Rep. 2022;14(3):413-9. DOI: https://doi.org/10.3390/idr14030044
Valent P, Lechner K. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: A clinical review. Wien Klin Wochenschr. 2008;120(5-6):136-51. DOI: https://doi.org/10.1007/s00508-008-0945-1
Shizuma T. Autoimmune hemolytic anemia following influenza virus infection or administration of influenza vaccine. J Blood Disorders Transf. 2014;5(3):1000200. DOI: https://doi.org/10.4172/2155-9864.1000200
Iida T, Sato S, Nakagaki S, Shimizu H, Kaneto H. Autoimmune hemolytic anemia triggered by infection with human parvovirus B19 after total abdominal colectomy for ulcerative colitis. Intern Med. 2016;55(6):677-81. DOI: https://doi.org/10.2169/internalmedicine.55.5657
Chaturvedi S, Chang A, McCrae KR. Long term outcomes of warm and cold antibody-mediated autoimmune hemolytic anemia treated with rituximab from a 13 year retrospective cohort. Blood. 2014;124(21):4009. DOI: https://doi.org/10.1182/blood.V124.21.4009.4009
Voulgaridou A, Kalfa TA. Autoimmune hemolytic anemia in the pediatric setting. J Clin Med. 2021;10(2):216. DOI: https://doi.org/10.3390/jcm10020216
Xie J, Chaaya G, Jetly-Shridhar R, Atkinson TS. Double hit: Evans syndrome after malignant thymoma treatment and parvovirus B19 infection. BMJ Case Rep. 2020;13(3):e233485. DOI: https://doi.org/10.1136/bcr-2019-233485
Kanu VSVR, Ilamurugan GP, Wasnik PN, Das P, Satarkar R. Autoimmune haemolytic anaemia associated with haemophagocytic lymphohistiocytosis secondary to Epstein–Barr virus infection. J Clin Sci Res. 2025;14(3):195-9. DOI: https://doi.org/10.4103/jcsr.jcsr_5_25
Chang A, Chaturvedi S, McCrae KR. Thirteen year retrospective analysis of adult patients with autoimmune hemolytic anemia at the Cleveland Clinic: Diagnosis and prevalence of associated disorders. Blood. 2013;122(21):955. DOI: https://doi.org/10.1182/blood.V122.21.955.955
Landry ML. Parvovirus B19. Microbiol Spectr. 2016;4(3). DOI: https://doi.org/10.1128/microbiolspec.DMIH2-0008-2015
Vadlamudi G, Rezuke WN, Ross J, Cartun RW, Ackroyd R, Knibbs DR, et al. The use of monoclonal antibody R92F6 and polymerase chain reaction to confirm the presence of parvovirus B19 in bone marrow specimens of patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1999;123(9):768-73. DOI: https://doi.org/10.5858/1999-123-0768-TUOMAR
Lindahl JP, Barlinn R, Abrahamsen IW, Spetalen S, Midtvedt K, Jenssen T. Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone. Front Med. 2022;9:849783. DOI: https://doi.org/10.3389/fmed.2022.849783
Song SA, Lee MY, Kim SH, Lee JY, Oh SH, Shin JH, et al. Autoimmune hemolytic anemia after aplastic crisis due to parvovirus B19 infection in a patient with hereditary spherocytosis. Lab Med Online. 2012;2(3):166. DOI: https://doi.org/10.3343/lmo.2012.2.3.166
Ho JK, Tha S, Coupland R, Dalal BI, Bowie W, Sreenivasan G, et al. Parvovirus B19 in an immunocompetent adult patient with acute liver failure: An underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol. 2005;19(3):161-2. DOI: https://doi.org/10.1155/2005/853947
Ma X, Hou N, Li C, Feng Y, Zhang X, Li S, et al. Parvovirus B19–induced aplastic anemia following mechanical valve replacement. J Int Med Res. 2025;53(9):03000605251377626. DOI: https://doi.org/10.1177/03000605251377626
Dereu A, Hellinckx J, Mondelaers V. Drie gezichten van pediatrische sferocytose: Een retrospectieve casusreeks uit een regionaal ziekenhuis. Tijdschr Geneeskd. 2025. DOI: https://doi.org/10.47671/TVG.81.25.009
Downloads
Published
How to Cite
Issue
Section
